Biodexa Pharmaceuticals Plc

BDRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$6-$7-$8-$5
Dep. & Amort.$0$0$0$0
Deferred Tax-$0-$0-$1$0
Stock-Based Comp.$0$0$0$0
Change in WC-$4-$0$1-$1
Other Non-Cash-$3$0$0-$1
Operating Cash Flow-$12-$7-$7-$6
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1-$0-$0$0
Investing Cash Flow-$1-$0-$0-$0
Financing Activities
Debt Repay.$0-$0-$0-$0
Stock Issued$8$10$0$9
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$0-$0
Financing Cash Flow$9$10$0$9
Forex Effect$0$0$0-$0
Net Chg. in Cash-$4$3-$7$3
Supplemental Information
Beg. Cash$6$3$10$8
End Cash$2$6$3$10
Free Cash Flow-$13-$7-$7-$6
Biodexa Pharmaceuticals Plc (BDRX) Financial Statements & Key Stats | AlphaPilot